http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2113258-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be4eba9539585114cd0e90a237a5246a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-83 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-83 |
| filingDate | 2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a715f45fa1e38bfb9873c752b212bd0 |
| publicationDate | 2009-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2113258-A1 |
| titleOfInvention | Aurone derivative-containing composition for diagnosis |
| abstract | The present invention provides a composition for diagnosing amyloid-related diseases, comprising a compound represented by general formula (I):n nwherein X represents O or the like; R 1 , R 3 , R 4 , R 5 , R 6 , R 8 and R 9 represent a hydrogen atom or the like; R 2 represents a halogen atom or the like; and R 7 represents a dimethylamino group or the like; nor the compound labeled with a radionuclide, or a pharmaceutically acceptable salt of the compound or the labeled compound. The compound represented by general formula (I) has all of the following properties: high binding specificity to amyloid β protein, high permeability through the blood-brain barrier, and rapid clearance from sites without senile plaques in the brain. |
| priorityDate | 2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.